Previous Close | 0.0000 |
Open | 0.1238 |
Bid | 0.2200 x 0 |
Ask | 0.2300 x 0 |
Day's Range | 0.1100 - 0.1238 |
52 Week Range | 0.0100 - 1.5500 |
Volume | |
Avg. Volume | 9,712 |
Market Cap | 8.826M |
Beta (5Y Monthly) | 1.45 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.9400 |
Earnings Date | Nov 15, 2024 - Nov 18, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.66 |
Optimization Initiatives Lead to Quarter-over-Quarter Improvements in Profitability and Positive Cash Flow from OperationsDENVER, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced preliminary financial and operational results for the third quarter ended September 30, 2024. “We continued to generate momentum from our retail growth and optimization initiatives in Q3, reflected by our
Growth and Restructuring Initiatives Lead to Quarter-over-Quarter Growth Across all Key Financial Metrics in Q2 Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the second quarter ended June 30, 2024. “We made solid progress on our growth and optimization initia